Response to Federal Recommendation to Delay Hep B Vaccine for Newborns

A recent recommendation from the federal Advisory Committee on Immunization Practices (ACIP) has sparked significant concern among pediatric leaders across the country. On December 5, ACIP voted to recommend delaying the hepatitis B vaccine for most newborns whose mothers test negative for the virus. Under this proposal, families would be encouraged to discuss with their healthcare providers whether to administer the birth dose or wait until the baby is at least two months old. The recommendation will not take effect unless approved by the CDC’s acting director or the U.S. health secretary.

The suggested delay has been met with strong criticism. The American Academy of Pediatrics (AAP) quickly reaffirmed its long-standing guidance: newborns should continue receiving the hepatitis B vaccine at birth, regardless of maternal status. AAP President Dr. Susan Kressly emphasized that postponing the first dose would put infants at unnecessary risk during their most vulnerable period. “They are vulnerable when we have a duty to most protect them. I urge parents to talk to their pediatrician and get the hepatitis B vaccine at birth,” she said.

Medical experts echoed these concerns. Dr. James Campbell, vice chair of the AAP’s Committee on Infectious Diseases, called the ACIP recommendation “a very dangerous decision” and warned that delayed vaccination could lead to preventable infections. He noted that, in his own clinical experience, infants who missed the early hepatitis B dose were more likely to contract the virus later in childhood.

Some federal lawmakers have also raised alarms. Sen. Bill Cassidy publicly opposed the recommendation, arguing that it could make the U.S. “sicker” by weakening a critical layer of childhood disease prevention.

As the proposal moves to federal leadership for review, the AAP’s message remains clear: the hepatitis B birth dose is a proven, lifesaving measure that protects infants from a serious viral infection. Families with questions are encouraged to speak with their pediatrician and rely on guidance grounded in decades of evidence-based practice.